Activation of rapid oestrogen signalling in aggressive human breast cancers
Open Access
- 15 October 2012
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 4 (11), 1200-1213
- https://doi.org/10.1002/emmm.201201615
Abstract
Oestrogen receptors can mediate rapid activation of cytoplasmic signalling cascades by recruiting Src and PI3K. However, the involvement of this pathway in breast cancer remains poorly defined. We have previously shown that methylation of ERα is required for the formation of the ERα/Src/PI3K complex and that ERα is hypermethylated in a subset of breast cancers. Here, we used Proximity Ligation Assay to demonstrate that this complex is present in the cytoplasm of breast cancer cell lines as well as formalin‐fixed, paraffin‐embedded tumours. Of particular interest, the analysis of 175 breast tumours showed that overexpression of this complex in a subset of breast tumours correlates to the activation of the downstream effector Akt. Survival analysis revealed that high expression of this complex is an independent marker of poor prognosis and associated with reduced disease‐free survival. Our data introduces the new concept that the rapid oestrogen pathway is operative in vivo. It also provides a rationale for patient stratification defined by the activation of this pathway and the identification of target therapies.Keywords
This publication has 39 references indexed in Scilit:
- Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 StudyClinical Cancer Research, 2011
- Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapyAnnals of Oncology, 2011
- Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivoBreast Cancer Research and Treatment, 2010
- Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumorsCancer Treatment Reviews, 2010
- Estradiol Abrogates Apoptosis in Breast Cancer Cells through Inactivation of BAD: Ras-dependent Nongenomic Pathways Requiring Signaling through ERK and AktD⃞Molecular Biology of the Cell, 2004
- Characterization of the Interactions of Estrogen Receptor and MNAR in the Activation of cSrcMolecular Endocrinology, 2004
- p130Cas interacts with estrogen receptor α and modulates non-genomic estrogen signaling in breast cancer cellsJournal of Cell Science, 2004
- Mediator and p300/CBP-Steroid Receptor Coactivator Complexes Have Distinct Roles, but Function Synergistically, during Estrogen Receptor α-Dependent Transcription with Chromatin TemplatesMolecular and Cellular Biology, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cellsThe EMBO Journal, 2001